IP Library Granted Patent US 9,081,010
Granted Patent B2
US 9,081,010 · App. 14/500,632 · Granted Jul 14, 2015

Aptamers for clostridium difficile diagnostics

Inventors: Urs Ochsner (Denver, CO); Evaldas Katilius (Superior, CO); Nebojsa Janjic (Boulder, CO)
Assignee: SOMALOGIC, INC.
G01N33/573G01N2333/91102
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,081,010
App. No.
14/500,632
Granted
Jul 14, 2015
Kind
B2
Abstract

The present disclosure relates generally to the field of nucleic acids and, more particularly, to aptamers capable of binding to toxins produced by Clostridium difficile ; diagnostic kits and methods comprising such aptamers; and methods of making and using such aptamers.

Claims (12)

1. A method of detecting the presence of a C. difficile toxin in a test sample comprising contacting said test sample with an aptamer that binds to C. difficile toxin A wherein said aptamer comprises SEQ ID NO: 9.

2. The method of claim 1 , wherein said aptamer further comprises at least one additional chemical modification, wherein said at least one additional chemical modification is a chemical substitution at one or more positions independently selected from the group consisting of a ribose position, a deoxyribose position, a phosphate position, and a base position.

3. The method of claim 2 , wherein said at least one additional chemical modification is independently selected from the group consisting of a 2′-amino (2′-NH 2 ), a 2′-fluoro (2′-F), a 2′-O-methyl (2′-OMe), a modification at a cytosine exocyclic amine, a substitution of 5-bromouracil, a substitution of 5-bromodeoxyuridine, a substitution of 5-bromodeoxycytidine, a backbone modification, methylation, a 3′ cap, and a 5′ cap.

4. The method of claim 1 , wherein said aptamer has a K d for C. difficile toxin A of 30 nM or less.

5. The method of claim 1 , wherein said aptamer is nuclease resistant.

6. The method of claim 1 , wherein said aptamer has a slow off rate.

7. The method of claim 1 , wherein the method of detecting is selected from a pull-down assay, dot blot assay, PCR assay or sandwich assay.

8. The method of claim 7 , wherein the method of detecting is a sandwich assay.

9. The method of claim 8 , wherein the sandwich assay is an aptamer-target-antibody assay wherein the aptamer is immobilized on a substrate and the antibody is used to detect target bound to the immobilized aptamer.

10. The method of claim 8 , wherein the sandwich assay is an antibody-target-aptamer assay wherein the antibody is immobilized on a substrate and the aptamer is used to detect target bound to the immobilized antibody.

11. The method of claim 8 , wherein the sandwich assay is an aptamer-target-aptamer assay wherein a first aptamer is immobilized on a substrate and a second aptamer is used to detect target bound to the first, immobilized aptamer.

12. The method of claim 7 , wherein the method of detecting provides a quantitative measure of C. difficile toxin A.

Assignments (5)
MERGER AND CHANGE OF NAME Recorded Jan 14, 2022
From: SOMALOGIC, INC.; SOMALOGIC OPERATING CO., INC.
To: SOMALOGIC OPERATING CO., INC.
Reel/Frame 058736/0574 →
RELEASE OF SECURITY INTEREST Recorded Apr 20, 2021
From: MADRYN HEALTH PARTNERS, LP, FORMERLY VISIUM HEALTHCARE PARTNERS, LP
To: SOMALOGIC, INC.
Reel/Frame 055981/0884 →
CHANGE OF NAME Recorded Mar 8, 2017
From: VISIUM HEALTHCARE PARTNERS, LP
To: MADRYN HEALTH PARTNERS, LP
Reel/Frame 041920/0957 →
SECURITY INTEREST Recorded Feb 29, 2016
From: SOMALOGIC, INC.
To: VISIUM HEALTHCARE PARTNERS, LP
Reel/Frame 037853/0211 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 3, 2014
From: OCHSNER, URS; KATILIUS, EVALDAS; JANJIC, NEBOJSA
To: SOMALOGIC, INC.
Reel/Frame 033880/0546 →
Continuity (3)
Division 13417035 · Mar 9, 2012
Provisional Application 61451227 · Mar 10, 2011
Related Publication 20150125867A1 · May 7, 2015